Tempest Therapeutics Inc. (TPST) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Tempest Therapeutics Inc.

    NASDAQ: TPST · Real-Time Price · USD
    10.85
    -0.14 (-1.27%)
    At close: Sep 08, 2025, 3:59 PM
    11.20
    3.23%
    After-hours: Sep 08, 2025, 07:51 PM EDT

    Tempest Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -41.84M -29.49M -35.71M -28.3M
    Depreciation & Amortization
    		 389K 381K 638K 374K
    Stock-Based Compensation
    		 5.3M 2.55M 1.56M 1.1M
    Other Working Capital
    		 8K -2.41M 867K -404K
    Other Non-Cash Items
    		 1.51M 1.88M 1.57M 1.48M
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 1.61M -2.68M 868K -613K
    Operating Cash Flow
    		 -33.03M -27.36M -31.07M -25.96M
    Capital Expenditures
    		 -435K -170K -562K -135K
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a 38K
    Investing Cash Flow
    		 -435K -170K -562K -97K
    Debt Repayment
    		 -4.4M n/a -4.74M 15M
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 307K n/a n/a 10.64M
    Financial Cash Flow
    		 24.5M 35.6M 11.4M 59.06M
    Net Cash Flow
    		 -8.96M 8.07M -20.23M 33.01M
    Free Cash Flow
    		 -33.46M -27.53M -31.63M -26.09M

    Add to Watchlist